8 research outputs found
Relationships Between Lower Body Muscular Strength and Power After Downhill Running
The purpose of this investigation was to assess relationships between maximal isometric lower body strength and three different measurements of maximal lower body neuromuscular power after a bout of eccentric lower body exercise. Forty-eight recreationally active males performed 20 minutes of downhill running (7.5 mph, -10% grade). Isometric knee extensor strength (KE), maximal cycling power (PMAX), vertical jump height (VJ), and 10-meter sprint time (10m) were assessed immediately prior to exercise (baseline) and repeated 2, 24, 48, 72, and 96 h after exercise. Data are reported as mean±SEM. There was a significant effect of time on all measurements throughout the 96 h period after exercise. Isometric KE strength was 129.0±3.3, 113.2±3.3, 115.8±3.3, 119.0±3.2 118.1±3.3 and 119.7±3.4 kg at baseline, 2, 24, 48, 72, and 96 h post-exercise, respectively. PMAX was 1086±31, 1014±28, 1024±32, 1042±31, 1042±30, and 1044±31 watts at baseline, 2, 24, 48, 72, and 96-hours post-exercise, respectively. VJ was 50.2±1.2, 48.7±1.2, 49.1±1.3, 49.7±1.3, 50.6±1.3, and 50.5±1.3 cm at baseline, 2, 24, 48, 72, and 96-hours post-exercise, respectively. 10m sprint time was 1.76±0.02, 1.80±0.03, 1.80±0.02, 1.79±0.02, 1.77±0.02, and 1.77±0.02 sec at baseline, 2, 24, 48, 72, and 96-hours post-exercise, respectively. There were significant relationships between isometric KE strength and both PMAX (R2=0.31, p\u3c0.05) and VJ height (R2=0.11, p\u3c0.05). Additionally, there was a significant relationship between isometric KE strength and Pmax at each time point (R2=0.23-0.34, p\u3c0.05). This was not true for VJ height or 10m sprint time. No relationship was present between isometric KE strength and 10m sprint time (R2=0.01). The primary finding of this study was a significant relationship between isometric KE strength and PMAX and that this relationship was maintained at each time point after eccentric exercise. Therefore, we conclude that PMAX is a reliable method to assess decrements in neuromuscular power and athletic performance after a bout of muscle damaging eccentric exercise
Impact of Polyphenol Antioxidants on Cycling Performance and Cardiovascular Function
This investigation sought to determine if supplementation with polyphenol antioxidant (PA) improves exercise performance in the heat (31.5 °C, 55% RH) by altering the cardiovascular and thermoregulatory responses to exercise. Twelve endurance trained athletes ingested PA or placebo (PLAC) for 7 days. Consecutive days of exercise testing were performed at the end of the supplementation periods. Cardiovascular and thermoregulatory measures were made during exercise. Performance, as measured by a 10 min time trial (TT) following 50 min of moderate intensity cycling, was not different between treatments (PLAC: 292 ± 33 W and PA: 279 ± 38 W, p = 0.12). Gross efficiency, blood lactate, maximal neuromuscular power, and ratings of perceived exertion were also not different between treatments. Similarly, performance on the second day of testing, as assessed by time to fatigue at maximal oxygen consumption, was not different between treatments (PLAC; 377 ± 117 s vs. PA; 364 ± 128 s, p = 0.61). Cardiovascular and thermoregulatory responses to exercise were not different between treatments on either day of exercise testing. Polyphenol antioxidant supplementation had no impact on exercise performance and did not alter the cardiovascular or thermoregulatory responses to exercise in the heat
Impact of Polyphenol Antioxidants on Cycling Performance and Cardiovascular Function
This investigation sought to determine if supplementation with polyphenol antioxidant (PA) improves exercise performance in the heat (31.5 °C, 55% RH) by altering the cardiovascular and thermoregulatory responses to exercise. Twelve endurance trained athletes ingested PA or placebo (PLAC) for 7 days. Consecutive days of exercise testing were performed at the end of the supplementation periods. Cardiovascular and thermoregulatory measures were made during exercise. Performance, as measured by a 10 min time trial (TT) following 50 min of moderate intensity cycling, was not different between treatments (PLAC: 292 ± 33 W and PA: 279 ± 38 W, p = 0.12). Gross efficiency, blood lactate, maximal neuromuscular power, and ratings of perceived exertion were also not different between treatments. Similarly, performance on the second day of testing, as assessed by time to fatigue at maximal oxygen consumption, was not different between treatments (PLAC; 377 ± 117 s vs. PA; 364 ± 128 s, p = 0.61). Cardiovascular and thermoregulatory responses to exercise were not different between treatments on either day of exercise testing. Polyphenol antioxidant supplementation had no impact on exercise performance and did not alter the cardiovascular or thermoregulatory responses to exercise in the heat